Review of immune checkpoint inhibitors in immuno-oncology.

Jacob, Jennifer B; Jacob, Mark K; Parajuli, Prahlad

Jacob, Jennifer B; Jacob, Mark K; Parajuli, Prahlad.

Afiliação

Jacob JB; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States. Electronic address: jacobj@wayne.edu.
Jacob MK; Michigan State University School of Human Medicine, East Lansing, MI, United States.
Parajuli P; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States.

Adv Pharmacol ; 91: 111-139, 2021.

Article em En | MEDLINE | ID: mdl-34099106

Assuntos

Inibidores de Checkpoint Imunológico; Neoplasias; Anticorpos Monoclonais/uso terapêutico; Humanos; Imunoterapia; Neoplasias/tratamento farmacológico

Palavras-chave

CTLA-4; Cancer immunotherapy; Checkpoint inhibitors; Immune checkpoint; Immune-related adverse events; PD-1; PD-L1; Programmed death receptor 1; Toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google